Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP807442.RAfvxP0UaXwZAu7oZd9yx-rBsn8ACBBYR9rCwNiNk1bMs130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP807442.RAfvxP0UaXwZAu7oZd9yx-rBsn8ACBBYR9rCwNiNk1bMs130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP807442.RAfvxP0UaXwZAu7oZd9yx-rBsn8ACBBYR9rCwNiNk1bMs130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP807442.RAfvxP0UaXwZAu7oZd9yx-rBsn8ACBBYR9rCwNiNk1bMs130_provenance.
- NP807442.RAfvxP0UaXwZAu7oZd9yx-rBsn8ACBBYR9rCwNiNk1bMs130_assertion description "[The length of the EGFR intron 1 CA repeats does not correlate with levels of EGFR expression and cannot be used as marker of clinical prognosis in pancreatic cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP807442.RAfvxP0UaXwZAu7oZd9yx-rBsn8ACBBYR9rCwNiNk1bMs130_provenance.
- NP807442.RAfvxP0UaXwZAu7oZd9yx-rBsn8ACBBYR9rCwNiNk1bMs130_assertion evidence source_evidence_literature NP807442.RAfvxP0UaXwZAu7oZd9yx-rBsn8ACBBYR9rCwNiNk1bMs130_provenance.
- NP807442.RAfvxP0UaXwZAu7oZd9yx-rBsn8ACBBYR9rCwNiNk1bMs130_assertion SIO_000772 20409526 NP807442.RAfvxP0UaXwZAu7oZd9yx-rBsn8ACBBYR9rCwNiNk1bMs130_provenance.
- NP807442.RAfvxP0UaXwZAu7oZd9yx-rBsn8ACBBYR9rCwNiNk1bMs130_assertion wasDerivedFrom befree-2016 NP807442.RAfvxP0UaXwZAu7oZd9yx-rBsn8ACBBYR9rCwNiNk1bMs130_provenance.
- NP807442.RAfvxP0UaXwZAu7oZd9yx-rBsn8ACBBYR9rCwNiNk1bMs130_assertion wasGeneratedBy ECO_0000203 NP807442.RAfvxP0UaXwZAu7oZd9yx-rBsn8ACBBYR9rCwNiNk1bMs130_provenance.
- befree-2016 importedOn "2016-02-19" NP807442.RAfvxP0UaXwZAu7oZd9yx-rBsn8ACBBYR9rCwNiNk1bMs130_provenance.